Results 31 to 40 of about 1,340,239 (214)

Masked diabetes insipidus in pituitary metastasis from breast cancer after thalamic biopsy: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Symptomatic pituitary metastasis is rare; furthermore, it can result in diabetes insipidus and panhypopituitarism. Since diabetes insipidus is masked by concurrent panhypopituitarism, it can impede the diagnosis of pituitary dysfunction.
Hiroaki Hashimoto   +5 more
doaj   +1 more source

Diabetes insipidus: Overview [PDF]

open access: yes, 2019
Diabetes insipidus is mainly characterized by polyuria, urinary volume over 3 L/day or 40mL/kg/day in adults, leading to subsequent polydipsia; these features are also present in most cases of diabetes mellitus.
Seema Sharma   +3 more
core   +1 more source

Diabetes insipidus

open access: yesLa Presse Médicale, 2021
Diabetes insipidus (DI) is a disorder characterized by a high hypotonic urinary output of more than 50ml per kg body weight per 24 hours, with associated polydipsia of more than 3 liters a day [1,2]. Central DI results from inadequate secretion and usually deficient synthesis of Arginine vasopressin (AVP) in the hypothalamus or pituitary gland. Besides
Mirjam Christ-Crain, Odile Gaisl
openaire   +2 more sources

Diabetes Insipidus: An Update.

open access: yes, 2020
The differential diagnosis of diabetes insipidus involves the distinction between central or nephrogenic diabetes insipidus and primary polydipsia. Differentiation is important because treatment strategies vary; the wrong treatment can be dangerous ...
Christ-Crain M, Refardt J, Winzeler B
core   +1 more source

Information about the statement of the working group on changing the name of diabetes insipidus: why it is relevant and should be supported in Ukraine

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2022
Diabetes is a term used to denote a wide range of di­seases. Diabetes mellitus unites conditions quite different in pathogenesis, but the leading feature for them is hyperglycemia and the complications caused by it.
V.I. Katerenchuk
doaj   +1 more source

Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a mutation in the arginine-vasopressin II gene in four generations of a Korean family [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2014
Autosomal dominant neurohypophyseal diabetes insipidus is a rare form of central diabetes insipidus that is caused by mutations in the vasopressin-neurophysin II (AVP-NPII) gene.
Myo-Jing Kim   +3 more
doaj   +1 more source

EVALUATION AND MANAGEMENT OF DIABETES INSIPIDUS.

open access: yes, 2021
Diabetes Insipidus is caused by a lack of antidiuretic hormone or ADH or a lack of response to antidiuretic hormone. The antidiuretic hormone acts on the collecting ducts in the kidneys and allows them to reabsorb water from the urine; having diabetes ...
Dr Awais Nazir Tarar, Dr Muhammad Ahmad Rauf. ,Dr Wajiha Kiran Awan.
core   +1 more source

Analysis of factors influencing the occurrence of diabetes insipidus following neuroendoscopic transsphenoidal resection of pituitary adenomas and risk assessment

open access: yesHeliyon
Objective: Studies have revealed a higher prevalence of diabetes insipidus in patients following resection of pituitary adenoma surgery. By comprehensively analysing the clinical history of patients undergoing endoscopic transnasal sphenoidal resection ...
Xiao-Jian Li   +8 more
doaj   +1 more source

Management of a patient with Sheehan’s syndrome and diabetes insipidus complicated by recurrent hyponatremia

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2021
A 38-year-old female was initially seen in the intensive care unit after severe postpartum hemorrhage. She was initially diagnosed to have Sheehan’s syndrome and after discharge, she was diagnosed to have a vesicovaginal fistula which initially caused a ...
Butheinah A Al-Sharafi   +2 more
doaj   +1 more source

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

open access: yesAngewandte Chemie, Volume 138, Issue 45, 2 November 2026.
Strategic incorporation of unnatural amino acids transforms macrocyclic peptides into drug‐like molecules capable of engaging challenging targets. These building blocks enhance stability, permeability, and bioavailability, accelerating the development of next‐generation peptide therapeutics.
Krishna K. Sharma   +5 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy